TRAVELLI, Cristina
 Distribuzione geografica
Continente #
EU - Europa 1.430
NA - Nord America 1.299
AS - Asia 837
SA - Sud America 109
AF - Africa 22
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 3.700
Nazione #
US - Stati Uniti d'America 1.257
RU - Federazione Russa 302
IE - Irlanda 255
CN - Cina 226
IT - Italia 219
SG - Singapore 198
DE - Germania 187
SE - Svezia 136
VN - Vietnam 123
HK - Hong Kong 111
UA - Ucraina 85
BR - Brasile 84
IN - India 71
FR - Francia 69
FI - Finlandia 49
GB - Regno Unito 44
TR - Turchia 32
CA - Canada 28
EE - Estonia 13
PL - Polonia 13
BE - Belgio 12
ID - Indonesia 12
AR - Argentina 10
ES - Italia 10
IR - Iran 10
IQ - Iraq 9
JP - Giappone 9
LT - Lituania 9
MX - Messico 9
CZ - Repubblica Ceca 7
ZA - Sudafrica 7
BD - Bangladesh 6
KR - Corea 5
NL - Olanda 5
PH - Filippine 5
AT - Austria 4
DZ - Algeria 4
EC - Ecuador 4
PK - Pakistan 4
VE - Venezuela 4
CO - Colombia 3
EG - Egitto 3
GR - Grecia 3
SA - Arabia Saudita 3
BJ - Benin 2
CL - Cile 2
JM - Giamaica 2
LB - Libano 2
MD - Moldavia 2
SN - Senegal 2
TN - Tunisia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CR - Costa Rica 1
DK - Danimarca 1
EU - Europa 1
GA - Gabon 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
MA - Marocco 1
MY - Malesia 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
RO - Romania 1
TH - Thailandia 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.700
Città #
Dublin 255
Jacksonville 156
Hong Kong 110
Ashburn 90
San Jose 84
Dearborn 83
Singapore 81
Beijing 79
Piemonte 75
Chandler 54
Wilmington 47
Ann Arbor 45
Ho Chi Minh City 36
Los Angeles 35
Hanoi 29
Moscow 28
Bremen 27
Lawrence 27
Princeton 27
Council Bluffs 25
Lauterbourg 24
Munich 24
New York 24
Ankara 19
Frankfurt am Main 19
San Mateo 17
Santa Clara 16
Helsinki 14
Dallas 13
São Paulo 13
Woodbridge 13
Andover 12
Montreal 12
Nanjing 12
Strasbourg 12
Houston 11
Warsaw 11
Brussels 10
Buffalo 10
Kecioeren 10
Milan 10
Orem 10
Chennai 9
Formigine 9
Redondo Beach 9
Toronto 9
Varallo 9
Dong Ket 8
Guangzhou 8
Nuremberg 8
Tokyo 8
Denver 7
Hangzhou 7
Hefei 7
Leawood 7
Poplar 7
Shanghai 7
Brno 6
Chicago 6
Columbus 6
Manchester 6
Turku 6
Zanjan 6
Boardman 5
Brooklyn 5
Chengdu 5
Da Nang 5
Falkenstein 5
Haiphong 5
Johannesburg 5
Kaunas 5
London 5
Seoul 5
Torino 5
Albano Laziale 4
Baghdad 4
Berlin 4
Brasília 4
Hillsboro 4
Jakarta 4
Mexico City 4
Nanchang 4
Paris 4
Phoenix 4
Stockholm 4
Turin 4
Vaiano Cremasco 4
Athens 3
Atlanta 3
Bacoli 3
Biên Hòa 3
Can Tho 3
Caracas 3
Charlotte 3
Fairfield 3
Grignasco 3
Guayaquil 3
Jeddah 3
Mülheim 3
Ninh Bình 3
Totale 2.010
Nome #
Identification of a novel NAMPT inhibitor by combinatorial click chemistry and chemical refinement 189
Design, synthesis, and biological evaluation of combretabenzodiazepines: a novel class of anti-tubulin agents 178
Targeting Transient Receptor Potential Vanilloid 1 (TRPV1) Channel Softly: The Discovery of Passerini Adducts as a Topical Treatment for Inflammatory Skin Disorders 168
Identification of Novel Triazole-Based Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors Endowed with Antiproliferative and Antiinflammatory Activity 166
Inhibitors of Nicotinamide Phosphoribosyltransferase, compositions, products and uses thereof. 159
Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is a tumoural cytokine released from melanoma 143
Combretabenzodiazepines: a novel class of antitubulin agents 138
Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors: novel modulators of antitumor immunity 137
Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed in melanoma lesions. 132
Triazole-curcuminoids: A new class of derivatives for 'tuning' curcumin bioactivities? 131
Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors. 130
The NAMPT inhibitor FK866 reverts the damage in spinal cord injury 130
Data on metabolic stability, aqueous solubility and CYP inhibition of novel triazole-based nicotinamide phosphoribosyltransferase (NAMPT) inhibitors 130
Characterization of NAD uptake in mammalian cells 129
The Cytokine Nicotinamide Phosphoribosyltransferase (eNAMPT; PBEF; Visfatin) Acts as a Natural Antagonist of C-C Chemokine Receptor Type 5 (CCR5) 124
Metabolic regulation of suppressive myeloid cells in cancer 123
Increased plasma nicotinamide phosphoribosyltransferase is associated with a hyperproliferative phenotype and restrains disease progression in MPN-associated myelofibrosis 122
Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine 122
NAMPT: A pleiotropic modulator of monocytes and macrophages 121
A novel potent nicotinamide phosphoribosyltransferase inhibitor synthesized via click chemistry 119
Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin): a new cytokine in tumour progression 115
Insight Into Nicotinamide Adenine Dinucleotide Homeostasis as a Targetable Metabolic Pathway in Colorectal Cancer 107
NAD depletion by FK866 induces autophagy 105
Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors are novel modulators of myeloid-derived suppressor cells 102
Targeting nicotinamide phosphoryltransferase (NAMPT) in inflammatory bowel disease 102
Extracellular nicotinamide phosphoribosyltransferase boosts IFNγ-induced macrophage polarization independently of TLR4 97
Reciprocal potentiation of the antitumoral activities of FK866, an inhibitor of nicotinamide phosphoribosyltransferase, and etoposide or cisplatin in neuroblastoma cells 90
null 77
Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin): a new cytokine in tumour progression 68
NAMPT and NAPRT serum levels predict response to anti-TNF therapy in inflammatory bowel disease 66
OXER1 and RACK1-associated pathway: a promising drug target for breast cancer progression 60
Totale 3.780
Categoria #
all - tutte 16.689
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.689


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111 0 0 0 0 0 0 0 0 0 0 0 11
2021/2022228 18 3 22 20 16 2 14 5 15 14 30 69
2022/2023603 30 22 33 5 49 61 26 34 279 2 35 27
2023/2024200 23 10 32 9 27 0 47 4 3 1 21 23
2024/2025406 7 9 27 12 18 25 40 36 66 47 17 102
2025/20261.394 73 57 94 249 154 86 144 258 101 98 58 22
Totale 3.780